JOHANNESBURG, Sept 2 (Reuters) - An alert and story on Sept. 2 saying South Africa's Aspen Pharmacare is in talks with Johnson & Johnson relating to the manufacturing of a COVID-19 vaccine is withdrawn. The alert and story related to a December 2020 presentation and were issued in error. A substitute story will follow. STORY_NUMBER: J8N2KV00J STORY_DATE: 02/09/2021 STORY_TIME: 0615 GMT
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
227.7 ZAR | +0.46% | +3.18% | +11.90% |
03-08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
03-05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.90% | 5.47B | |
+21.41% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.21% | 13.79B | |
+48.11% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
-4.01% | 4.81B |
- Stock Market
- Equities
- APN Stock
- News Aspen Pharmacare Holdings Limited
- Aspen Pharmacare : Alert and story withdrawn on Aspen and J&J in talks to produce COVID vaccine